CDs | Bioimaging | Polarity-sensitive and Golgi targeting | Golgi imaging and real-time tracking | 2023 | [17] |
OR-CDs | Viscosity sensitive and lysosomal targeting | Lysosome imaging and viscosity change monitoring | 2023 | [18] |
Mn-doped CDs | Green synthesis and low cytotoxicity | Imaging of brain glioma by fluorescence and MRI | 2018 | [20] |
CDs | Biocompatibility, high quantum yield, and fluorescence stability | Imaging of silkworm and producing fluorescent silk | 2022 | [21] |
N, S-CDs | Disease diagnosis | pH and arginine sensitivity, biocompatibility, and low cytotoxicity | Physiological environment pH detection | 2023 | [25] |
N-CDs | Being specific for glycolytic metabolism | Cellular glycolysis imaging | 2021 | [26] |
N, F-CDs | Cytochrome C sensitivity, temperature sensitivity, and high quantum yield | Recovery of CytC from serum | 2021 | [31] |
BN-L-CDs | Dual wavelength emission, low toxicity, and sensitivity and specificity to creatine kinase | Visual detection of heart disease | 2023 | [32] |
MGA-CDs | Disease treatment | Blood-brain barrier permeability and tumor mitochondrial targeting | Intracranial tumor suppression | 2023 | [42] |
pH-CDs-Fe | Peroxidase activity, photothermal effect, and chemodynamic therapeutic properties | Tumor cell therapy | 2018 | [43] |
QCDs | Broad-spectrum antibacterial activity and inhibition of Gram-negative bacteria | Polar peritonitis caused by escherichia coli | 2023 | [45] |
LCDs | Low drug resistance, antimicrobial activity, and biocompatibility | Bacterial infection and animal infection with pneumonia | 2022 | [50] |
BWE-CDs | Green, low toxicity, and antioxidant and anti-inflammatory activity | Treating inflammation in zebrafish | 2023 | [48] |
CDs-CLD-hFGF2 | Peroxidase activity and free radical scavenging activity | Skin wound healing | 2023 | [49] |